ENVERIC BIOSCIENCES INC (ENVB) Stock News
NASDAQ:ENVB - Nasdaq - US29405E4061 - Common Stock - Currency: USD
ENVB Latest News, Press Relases and Analysis
All
Press Releases
21 days ago - Enveric Biosciences
Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003
a month ago - Enveric Biosciences
Enveric Biosciences Announces Participation in 2025 BIO International Convention
a month ago - Enveric Biosciences
Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
2 months ago - Enveric Biosciences
Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003
2 months ago - Enveric Biosciences
Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease
2 months ago - Enveric Biosciences
Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results
4 months ago - Enveric Biosciences
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024
4 months ago - Enveric Biosciences, Inc.
Enveric Biosciences Participating in BIO-Europe Spring®
4 months ago - Enveric Biosciences
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
5 months ago - Enveric Biosciences
Enveric Biosciences CEO Issues Letter to Shareholders
5 months ago - Enveric Biosciences
Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent
5 months ago - Enveric Biosciences
Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
5 months ago - Enveric Biosciences, Inc.
Enveric Biosciences Announces Closing of $5 Million Public Offering
6 months ago - Enveric Biosciences, Inc.